Applied Clinical Trials
The latest eclinical software in the clinical trials industry.
News
Advertisement
Applied Clinical Trials
The growing adoption rate of EDC will enable companies to reap the benefits of the entire eClinical suite.
Advertisement
Applied Clinical Trials
Vital players come together in an attempt to find a cure for a devastating illness predominantly effecting African countries.
Applied Clinical Trials
A look at the growing market of dietary supplements and the potential for development of these products in the clinical trials arena.
Applied Clinical Trials
Proactive risk management helps pharma protect their product development investments and future.
Applied Clinical Trials
Industry news focusing on the people and organizations who work in the clinical trials profession.
Advertisement
Applied Clinical Trials
Three-phase approach to make a midstudy vendor transition less painful.
Company News Release
Advertisement
Company News Release
Applied Clinical Trials
Findings show big pharma increasingly turning to other companies for molecules to stock its pipeline.
Company News Release
Company News Release
Applied Clinical Trials
Is ensuring integrity within the clinical trials enterprise, as some claim, beyond the reach of industry?
Company News Release
Info for Authors
Applied Clinical Trials
Lisa Henderson discusses industry's advice on handling the potentially trial altering occurrence of EDC vendor merges.
Applied Clinical Trials
A Revolution in Physician Targeting: In-source analytics-driven intelligence to go beyond decile-based targeting - SAS Whitepaper
New Dimensions in EDC/eClinical - TMF and Document Management - ACT Whitepaper
Company News Release
Company News Release
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters
2
ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap
3
ACT Brief: Funding Gaps and Indication Decisions in Early-Stage Programs, Recruitment Funnel Leak Diagnosis, and Mega-Merger Speculation Denial
4
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
5